All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
TALIS BIOMEDICAL CORP Last Reported: 4/30/2024 Stock Symbol: TLIS

Business Address

1100 ISLAND DRIVE
SUITE 101
REDWOOD CITY , CA US 94065

Mailing Address

1100 ISLAND DRIVE
SUITE 101
REDWOOD CITY , CA US 94065
Phone Number: 650-433-3000 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 7/31/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 2/28/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $76,732,000.00 $87,996,000.00 $98,200,000.00 $130,191,000.00 $143,783,000.00 -- $165,400,000.00 $232,545,000.00 $273,600,000.00 $313,500,000.00 $348,012,000.00 -- $138,483,000.00 $55,406,000.00 $115,272,000.00 $15,908,000.00 --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- $2,027,000.00 -- $2,219,000.00 -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $901,000.00 $1,531,000.00 $2,223,000.00 $2,783,000.00 $4,134,000.00 -- $5,738,000.00 $3,387,000.00 $2,797,000.00 $3,209,000.00 $3,448,000.00 -- $3,106,000.00 -- -- -- --
Total Current Assets $77,683,000.00 $89,532,000.00 $101,965,000.00 $133,282,000.00 $150,377,000.00 -- $173,966,000.00 $236,115,000.00 $277,557,000.00 $353,865,000.00 $391,322,000.00 -- $188,724,000.00 -- -- -- --
Property Plant and Equipement $3,030,000.00 $3,332,000.00 $3,539,000.00 $3,312,000.00 $6,869,000.00 -- $10,157,000.00 $10,528,000.00 $10,391,000.00 $10,178,000.00 $9,712,000.00 -- $9,114,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $1,542,000.00 $1,542,000.00 $1,542,000.00 $1,776,000.00 $1,776,000.00 -- $1,776,000.00 $6,278,000.00 $1,748,000.00 $1,748,000.00 $1,748,000.00 -- -- -- -- -- --
Total Assets $94,674,000.00 $107,228,000.00 $123,076,000.00 $169,290,000.00 $194,094,000.00 -- $221,690,000.00 $265,828,000.00 $303,096,000.00 $379,538,000.00 $403,182,000.00 -- $198,405,000.00 -- -- -- --
Accounts Payable $1,339,000.00 $2,697,000.00 $2,491,000.00 $3,768,000.00 $4,111,000.00 -- $3,978,000.00 $5,122,000.00 $5,388,000.00 $11,695,000.00 $10,826,000.00 -- $4,906,000.00 -- -- -- --
Accrued Liabilities $715,000.00 $637,000.00 $938,000.00 $989,000.00 $789,000.00 -- $2,539,000.00 $6,383,000.00 $18,194,000.00 $54,761,000.00 -- -- $7,694,000.00 -- -- -- --
Total Current Liabilities $25,558,000.00 $25,672,000.00 $26,910,000.00 $42,551,000.00 $41,708,000.00 -- $44,671,000.00 $31,851,000.00 $44,304,000.00 $85,806,000.00 -- -- $16,031,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $609,074,000.00 $608,054,000.00 $606,982,000.00 $604,687,000.00 $603,405,000.00 -- $602,017,000.00 $598,913,000.00 $595,075,000.00 $591,597,000.00 $589,726,000.00 -- $64,335,000.00 -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-539,961,000.00 $-526,501,000.00 $-510,819,000.00 $-477,954,000.00 $-451,025,000.00 -- $-425,004,000.00 $-364,942,000.00 $-336,288,000.00 $-297,870,000.00 $-233,398,000.00 -- $-172,906,000.00 -- -- -- --
Total Stockholders' Equity $69,116,000.00 $81,556,000.00 $96,166,000.00 $126,739,000.00 $152,386,000.00 -- $177,019,000.00 $233,977,000.00 $258,792,000.00 $293,732,000.00 $356,333,000.00 -- $-108,571,000.00 $-65,942,000.00 $-37,466,000.00 $-27,828,000.00 $-21,140,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $94,674,000.00 $107,228,000.00 $123,076,000.00 $169,290,000.00 $194,094,000.00 -- $221,690,000.00 $265,828,000.00 $303,096,000.00 $379,538,000.00 $403,182,000.00 -- $198,405,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 7/31/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 2/28/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues $2,134,000.00 $1,939,000.00 $581,000.00 $4,812,000.00 $4,555,000.00 -- $3,759,000.00 -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- $-440,000.00 -- $-1,064,000.00 -- -- -- -- -- -- -- -- -- --
Research and Development $40,694,000.00 $32,653,000.00 $24,351,000.00 $70,831,000.00 $17,521,000.00 -- $17,365,000.00 $157,591,000.00 $140,529,000.00 $114,688,000.00 $60,193,000.00 -- -- $36,011,000.00 $13,898,000.00 $5,714,000.00 --
Selling, General, and Administrative $28,214,000.00 $21,612,000.00 $6,410,000.00 $40,729,000.00 $29,933,000.00 -- $9,178,000.00 $42,418,000.00 $30,102,000.00 $17,310,000.00 $7,327,000.00 -- -- $7,798,000.00 $2,660,000.00 $2,080,000.00 --
Total Operating Expenses -- -- -- -- $85,522,000.00 -- $59,176,000.00 $200,009,000.00 $170,631,000.00 $131,998,000.00 $67,520,000.00 -- -- $57,707,000.00 $18,638,000.00 $7,794,000.00 --
Loss from Operations $-66,815,000.00 $-16,971,000.00 $-35,388,000.00 $-115,139,000.00 $-87,026,000.00 -- $-60,240,000.00 $-191,816,000.00 $-38,415,000.00 $-124,881,000.00 $-60,520,000.00 -- -- $-29,583,000.00 $-17,419,000.00 $-7,395,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-34.12 $-8.62 $-18.11 $-4.24 $-0.98 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 1,817,506 1,819,066 1,814,994 26,633,241 26,553,603 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-34.12 $-26.73 $-18.11 $-4.24 $-0.98 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 1,817,506 1,816,294 1,814,994 26,633,241 26,646,205 -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 -- 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 230,000,000 -- -- -- --
Common Stock Shares Outstanding 1,821,986 1,819,136 1,819,029 26,795,800 26,781,915 -- 26,618,920 26,408,031 25,963,014 25,690,373 25,637,581 -- 2,126,254 -- -- -- --
Common Stock Value -- -- -- $3,000.00 $3,000.00 -- $3,000.00 $3,000.00 $2,000.00 $2,000.00 $2,000.00 -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $1.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- 170,000,000 170,000,000 170,000,000 170,000,000 -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- 29,863,674 29,863,674 29,863,674 -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com